Terms ending in 2041
Every in-force patent on Intervet Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,797,461 | Swine Influenza a Virus Vaccine Comprising a Nucleic Acid Construct Comprising First, Second and Third Nucleic Acid Sequences Encoding Distinct Neuraminidase Antigens of the Virus In force · Medium confidence | Intervet Inc. | In force | Medium confidence | |
| US 12,285,593 | Device for Administering a Fluid In force · Medium confidence | Intervet Inc. | In force | Medium confidence | |
| US 12,018,020 | Crystalline Forms of 1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]-3-[(2-Fluoro-6-Methoxy-4-Pyridyl)Amino]Pyrazole-4-Carboxamide In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 12,023,374 | A Vaccine for Protection Against Streptococcus Suis In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 12,161,713 | Prime-Boost Vaccination Regimen In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 12,297,459 | Novel Porcine Rotavirus In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 12,214,027 | Stabilisation of Live Mollicutes Bacteria in a Liquid Composition In force · High confidence | Intervet Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.